Form 4: Haemonetics Corp CEO Christopher Simon Reports Gift Transfer of Common Stock

Christopher Simon, President & CEO of Haemonetics Corp, reported a gift transfer of 38,900 shares of common stock to the Simon Family 2020 Irrevocable Trust on March 11, 2024.

Summary

• On March 11, 2024, Christopher Simon, the President & CEO of Haemonetics Corp, reported a transaction involving the company's common stock.
• Mr. Simon transferred 38,900 shares of common stock as a gift to the Simon Family 2020 Irrevocable Trust.
• The transfer was made without any consideration.
• Following the transaction, Mr. Simon directly owns 257,546 shares of Haemonetics Corp.
• This number includes unvested restricted stock units previously reported.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a gift transfer of shares. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of a transaction by a company insider and doesn't necessarily reflect a change in the company's outlook or performance. It is common for executives to manage their personal finances through trusts and gifting strategies.

Stakeholder Impact

• The transfer of shares to a family trust has minimal direct impact on stakeholders.

Key Dates